Armata Pharmaceuticals (ARMP) Equity Average (2016 - 2026)
Quarterly results put Equity Average at -$265.1 million for Q1 2026, down 420.8% from a year ago — trailing twelve months through Mar 2026 was -$265.1 million (down 420.8% YoY), and the annual figure for FY2025 was -$133.3 million, down 232.92%.
Armata Pharmaceuticals has reported Equity Average over the past 13 years, most recently at -$265.1 million for Q1 2026.
- Equity Average reached -$265.1 million in Q1 2026 per ARMP's latest filing, down from -$157.1 million in the prior quarter.
- Across five years, Equity Average topped out at $57.4 million in Q2 2022 and bottomed at -$265.1 million in Q1 2026.
- Median Equity Average over the past 5 years was -$44.3 million (2024), compared with a mean of -$34.6 million.
- The largest annual shift saw Equity Average soared 88.77% in 2022 before it plummeted 1536.64% in 2024.
- Over 5 years, Equity Average stood at $40.8 million in 2022, then plummeted by 154.44% to -$22.2 million in 2023, then tumbled by 122.7% to -$49.5 million in 2024, then plummeted by 217.38% to -$157.1 million in 2025, then tumbled by 68.75% to -$265.1 million in 2026.
- Business Quant data shows Equity Average for ARMP at -$265.1 million in Q1 2026, -$157.1 million in Q4 2025, and -$82.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.34 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -265.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -265.09 Mn |
| Dec 31, 2025 | -157.09 Mn |
| Sep 30, 2025 | -82.55 Mn |
| Jun 30, 2025 | -61.64 Mn |
| Mar 31, 2025 | -50.90 Mn |
| Dec 31, 2024 | -49.50 Mn |
| Sep 30, 2024 | -48.54 Mn |
| Jun 30, 2024 | -51.31 Mn |
| Mar 31, 2024 | -44.29 Mn |
| Dec 31, 2023 | -22.23 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Jun 30, 2023 | 20.80 Mn |
| Mar 31, 2023 | 29.26 Mn |
| Dec 31, 2022 | 40.83 Mn |
| Sep 30, 2022 | 49.43 Mn |
| Jun 30, 2022 | 57.42 Mn |
| Mar 31, 2022 | 43.47 Mn |
| Dec 31, 2021 | 24.58 Mn |
| Sep 30, 2021 | 26.19 Mn |
| Jun 30, 2021 | 31.32 Mn |
| Mar 31, 2021 | 26.43 Mn |
| Dec 31, 2020 | 21.74 Mn |
| Sep 30, 2020 | 27.13 Mn |
| Jun 30, 2020 | 31.56 Mn |
| Mar 31, 2020 | 24.04 Mn |
| Dec 31, 2019 | 16.36 Mn |
| Sep 30, 2019 | 20.38 Mn |
| Jun 30, 2019 | 13.29 Mn |
| Mar 31, 2019 | 5.82 Mn |
| Dec 31, 2018 | 8.25 Mn |
| Sep 30, 2018 | 10.18 Mn |
| Jun 30, 2018 | 13.13 Mn |
| Mar 31, 2018 | 19.52 Mn |
| Dec 31, 2017 | 17.05 Mn |
| Sep 30, 2017 | 9.81 Mn |
| Jun 30, 2017 | 8.25 Mn |
| Mar 31, 2017 | 8.19 Mn |
| Dec 31, 2016 | 13.98 Mn |
| Sep 30, 2016 | 19.86 Mn |
| Jun 30, 2016 | 15.19 Mn |